Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: Elanco Animal Health Incorporated, 2 years.
Elanco Animal Health Incorporated
Director
Mereo BioPharma Group plc
Director · Chief Executive Officer
Chief executive roles
Mereo BioPharma Group plc
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 29, 2024 | Elanco Animal Health Incorporated | Grant or award | +18,169 | — | — |
| Sep 13, 2024 | Mereo BioPharma Group plc | Open-market sale | −60,046 | $4.22 | $253,394 |
| Sep 12, 2024 | Mereo BioPharma Group plc | Open-market sale | −28,611 | $4.47 | $127,891 |
| Sep 11, 2024 | Mereo BioPharma Group plc | Option exercise | +188,060 | — | — |
| Jun 26, 2024 | Mereo BioPharma Group plc | Open-market sale | −92,273 | $3.39 | $312,805 |
| Jun 25, 2024 | Mereo BioPharma Group plc | Open-market sale | −40,712 | $3.69 | $150,227 |
| Jun 21, 2024 | Mereo BioPharma Group plc | Option exercise | +282,090 | — | — |
| Nov 30, 2023 | Elanco Animal Health Incorporated | Grant or award | +20,374 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.